IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer.
Martini
Matteo
M
Department of Pathology and Diagnostics, Immunology Section, University of Verona, Italy.
Testi
Maria Grazia
MG
Pasetto
Matteo
M
Picchio
Maria Cristina
MC
Innamorati
Giulio
G
Mazzocco
Marta
M
Ugel
Stefano
S
Cingarlini
Sara
S
Bronte
Vincenzo
V
Zanovello
Paola
P
Krampera
Mauro
M
Mosna
Federico
F
Cestari
Tiziana
T
Riviera
Anna Pia
AP
Brutti
Nadia
N
Barbieri
Ottavia
O
Matera
Lina
L
Tridente
Giuseppe
G
Colombatti
Marco
M
Sartoris
Silvia
S
D000230:Adenocarcinoma / Q000235:genetics / Q000276:immunology*; D000818:Animals; D018122:B7-1 Antigen / Q000235:genetics / Q000276:immunology; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D005805:Genes, MHC Class I; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology*; D007371:Interferon-gamma / Q000276:immunology*; D008297:Male; D059630:Mesenchymal Stem Cells / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000235:genetics / Q000276:immunology; D011471:Prostatic Neoplasms / Q000235:genetics / Q000276:immunology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000276:immunology; D015854:Up-Regulation
D018122:B7-1 Antigen; D015395:Histocompatibility Antigens Class I; D016212:Transforming Growth Factor beta; D007371:Interferon-gamma